Estrella Immunopharma, Inc., also known as ESLA, operates in the biopharmaceuticals industry. The company is focused on the development of CD19 and CD2
| S.No. | Ticker | Company | Market Cap | P/E | P/S | Total Debt (Qtr) |
|---|---|---|---|---|---|---|
| 1 | VKTX | Viking Therapeutics, Inc. | - | - | - | - |
| 2 | BOLT | Bolt Biotherapeutics, Inc. | - | - | - | - |
| 3 | GERN | Geron Corp | - | - | - | 119.55 Mn |
| 4 | VTVT | vTv Therapeutics Inc. | - | - | - | - |
| 5 | DYAI | Dyadic International Inc | - | - | - | - |
| 6 | VIR | Vir Biotechnology, Inc. | - | - | - | - |
| 7 | NAMS | NewAmsterdam Pharma Co N.V. | - | - | - | 57.27 Mn |
| 8 | RLYB | Rallybio Corp | - | - | - | - |